BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28941301)

  • 1. Cystatin C predicts acute kidney injury and mortality in cirrhotics: A prospective cohort study.
    Maiwall R; Kumar A; Bhardwaj A; Kumar G; Bhadoria AS; Sarin SK
    Liver Int; 2018 Apr; 38(4):654-664. PubMed ID: 28941301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, Risk Factors, and Outcomes of Transition of Acute Kidney Injury to Chronic Kidney Disease in Cirrhosis: A Prospective Cohort Study.
    Maiwall R; Pasupuleti SSR; Bihari C; Rastogi A; Singh PK; Naik V; Singh A; Jain P; Kumar A; Mukund A; Mathur RP; Kumar G; Sarin SK
    Hepatology; 2020 Mar; 71(3):1009-1022. PubMed ID: 31313333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute kidney injury defined by cystatin C may be superior for predicting the outcomes of liver cirrhosis with acute gastrointestinal bleeding.
    Hong C; Zhu Q; Li Y; Tang S; Lin S; Yang Y; Yuan S; Shao L; Wu Y; Liu B; Li B; Meng F; Chen Y; Hong M; Qi X
    Ren Fail; 2022 Dec; 44(1):398-406. PubMed ID: 35225149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment and prediction of acute kidney injury in patients with decompensated cirrhosis with serum cystatin C and urine N-acetyl-β-D-glucosaminidase.
    Kim TH; Lee HA; Seo YS; Lee YR; Yim SY; Lee YS; Suh SJ; Jung YK; Kim JH; An H; Yim HJ; Yeon JE; Byun KS; Um SH;
    J Gastroenterol Hepatol; 2019 Jan; 34(1):234-240. PubMed ID: 30062791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The discrepancy between serum creatinine and cystatin C can predict renal function after treatment for postrenal acute kidney injury: multicenter study and pooled data analysis.
    Matsuki M; Tanaka T; Maehana T; Kyoda Y; Ichihara K; Hashimoto K; Yanase M; Matsukawa M; Adachi H; Takahashi S; Masumori N
    Clin Exp Nephrol; 2017 Oct; 21(5):852-857. PubMed ID: 28258496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of definition of acute kidney injury by cystatin C rise with biomarkers and clinical outcomes in children undergoing cardiac surgery.
    Zappitelli M; Greenberg JH; Coca SG; Krawczeski CD; Li S; Thiessen-Philbrook HR; Bennett MR; Devarajan P; Parikh CR;
    JAMA Pediatr; 2015 Jun; 169(6):583-91. PubMed ID: 25844892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early serum cystatin C-enhanced risk prediction for acute kidney injury post cardiac surgery: a prospective, observational, cohort study.
    Wang X; Lin X; Xie B; Huang R; Yan Y; Liu S; Zhu M; Lu R; Qian J; Ni Z; Xue S; Che M
    Biomarkers; 2020 Feb; 25(1):20-26. PubMed ID: 31686541
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum cystatin C for acute kidney injury evaluation in children treated with aminoglycosides.
    Lau L; Al-Ismaili Z; Harel-Sterling M; Pizzi M; Caldwell JS; Piccioni M; Lands LC; Mottes T; Devarajan P; Goldstein SL; Bennett MR; Zappitelli M
    Pediatr Nephrol; 2017 Jan; 32(1):163-171. PubMed ID: 27743042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term mortality in patients with cirrhosis of the liver and acute kidney injury: A prospective observational study.
    Kumar U; Kumar R; Jha SK; Jha AK; Dayal VM; Kumar A
    Indian J Gastroenterol; 2020 Oct; 39(5):457-464. PubMed ID: 33175368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtle change of cystatin C, with or without acute kidney injury, associated with increased mortality in the intensive care unit.
    Kwon SH; Hyun J; Jeon JS; Noh H; Han DC
    J Crit Care; 2011 Dec; 26(6):566-71. PubMed ID: 21419594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and urine FGF23 and IGFBP-7 for the prediction of acute kidney injury in critically ill children.
    Bai Z; Fang F; Xu Z; Lu C; Wang X; Chen J; Pan J; Wang J; Li Y
    BMC Pediatr; 2018 Jun; 18(1):192. PubMed ID: 29907141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of biomarkers as predictors of acute kidney injury and mortality in decompensated cirrhosis.
    Jo SK; Yang J; Hwang SM; Lee MS; Park SH
    Sci Rep; 2019 Oct; 9(1):14508. PubMed ID: 31601879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystatin C: best biomarker for acute kidney injury and estimation of glomerular filtration rate in childhood cirrhosis.
    Vijay P; Lal BB; Sood V; Khanna R; Alam S
    Eur J Pediatr; 2021 Nov; 180(11):3287-3295. PubMed ID: 33978827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline serum cystatin C as a marker of acute kidney injury in patients with acute-on-chronic liver failure.
    Jha P; Jha AK; Dayal VM; Jha SK; Kumar A
    Indian J Gastroenterol; 2021 Dec; 40(6):563-571. PubMed ID: 34981441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Siglec-7 as a Novel Biomarker to Predict Mortality in Decompensated Cirrhosis and Acute Kidney Injury.
    Allegretti AS; Ortiz G; Kalim S; Wibecan J; Zhang D; Shan HY; Xu D; Chung RT; Karumanchi SA; Thadhani RI
    Dig Dis Sci; 2016 Dec; 61(12):3609-3620. PubMed ID: 27655105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure.
    Wan ZH; Wang JJ; You SL; Liu HL; Zhu B; Zang H; Li C; Chen J; Xin SJ
    World J Gastroenterol; 2013 Dec; 19(48):9432-8. PubMed ID: 24409073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystatin C and Sarcopenia Predict Acute on Chronic Liver Failure Development and Mortality in Patients on the Liver Transplant Waiting List.
    Mauro E; Crespo G; Martinez-Garmendia A; Gutierrez-Acevedo MN; Diaz JM; Saidman J; Bermudez C; Ortiz-Patron J; Garcia-Olveira L; Zalazar F; Narvaez A; Spina JC; Orta R; Savluk L; Piano S; Marciano S; Gadano A
    Transplantation; 2020 Jul; 104(7):e188-e198. PubMed ID: 32150034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystatin C in acute kidney injury diagnosis: early biomarker or alternative to serum creatinine?
    Lagos-Arevalo P; Palijan A; Vertullo L; Devarajan P; Bennett MR; Sabbisetti V; Bonventre JV; Ma Q; Gottesman RD; Zappitelli M
    Pediatr Nephrol; 2015 Apr; 30(4):665-76. PubMed ID: 25475610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystatin C as an early marker of acute kidney injury and predictor of mortality in the intensive care unit after acute myocardial infarction.
    Fouad M; Boraie M
    Arab J Nephrol Transplant; 2013 Jan; 6(1):21-6. PubMed ID: 23282229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of Serum Cystatin C Measurement in the Diagnosis of Sepsis-Induced Kidney Injury and Prediction of Renal Function Recovery.
    Leem AY; Park MS; Park BH; Jung WJ; Chung KS; Kim SY; Kim EY; Jung JY; Kang YA; Kim YS; Kim SK; Chang J; Song JH
    Yonsei Med J; 2017 May; 58(3):604-612. PubMed ID: 28332367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.